Brucella Serology and History of Brucellosis in Patients With Modic Changes Type 1
NCT ID: NCT04911283
Last Updated: 2021-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
118 participants
OBSERVATIONAL
2019-05-01
2020-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Design: In comparative cross-sectional design, MCs type 1 patients (study group) and MCs type 2 patients (comparator group) were examined in terms of Brucella serology by using agglutination with Coombs test. In addition, in comparative case-control design, both of the MCs groups and age/sex-matched healthy controls were investigated for their medical history regarding brucellosis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Serum Sclerostin Levels in Cholesteatoma Patients
NCT03954288
Ozone Therapy in Ankylosing Spondylitis
NCT05429801
Cytokines in Blister Fluids of Bullous Pemphigoid (BP)
NCT03856840
Annexin A1 Levels in SARS-CoV-2 Infection
NCT04948229
Comparison Of Doxycycline And Common Salt For Treatment Of Umbilical Granuloma: A Randomised Control Trial
NCT05545462
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MCs type 1 patients (study group; n=37)
Brucella serology test
MCs type 1 and type 2 patients were examined in terms of Brucella serology by using agglutination with Coombs test.
Medical history for brucellosis
Both of the MCs groups and healthy controls were investigated for their medical history regarding brucellosis.
MCs type 2 patients (comparator group; n=44)
Brucella serology test
MCs type 1 and type 2 patients were examined in terms of Brucella serology by using agglutination with Coombs test.
Medical history for brucellosis
Both of the MCs groups and healthy controls were investigated for their medical history regarding brucellosis.
healthy controls (n=37)
Medical history for brucellosis
Both of the MCs groups and healthy controls were investigated for their medical history regarding brucellosis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brucella serology test
MCs type 1 and type 2 patients were examined in terms of Brucella serology by using agglutination with Coombs test.
Medical history for brucellosis
Both of the MCs groups and healthy controls were investigated for their medical history regarding brucellosis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with lumbar Modic changes type 2
* Participant who given informed consent for the study
Exclusion Criteria
* History of serious lumbar trauma
* Lumbar spinal surgery
* Scoliosis
* Cooperation disorder
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Veysel Delen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Veysel Delen
Department of Physical Medicine and Rehabilitation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Veysel Delen
Role: PRINCIPAL_INVESTIGATOR
Mehmet Akif İnan Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mehmet Akif İnan Hospital
Sanliurfa, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SUEADH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.